Dr. Arndt Stüber, General Manager Demeditec, comments: “The field of cardiovascular diseases is becoming an important part of our core business and thus CardiNor’s Secretoneurin ELISA test is an excellent addition to our portfolio. We are convinced that our customers in the different territories will be offered an excellent diagnostic tool for research and routine”.
Dag Christiansen, CEO CardiNor, comments: “We are delighted to work with Demeditec Diagnostics, a company with extensive experience in distributing high quality laboratory research and clinical products in Germany and worldwide. Demeditec has a very strong position in the German market and the fact that they have an extensive network of partners in many countries around the world do provide CardiNor with an almost global market presence for our first-generation SN test”.
More information can be found at:
www.cardinor.com and www.demeditec.com